Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice. (Q38110707)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

main subject

mesenchymal stem cell

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Seok-Goo Cho

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Nayoun Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Keon-Il Im

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jung-Yeon Lim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Eun-Joo Jeon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Eun-Jung Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

31 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1295-1308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

Multilineage potential of adult human mesenchymal stem cells

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Adult bone marrow stromal cells differentiate into neural cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

How do mesenchymal stromal cells suppress T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

The immunomodulatory properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Bioimaging for the monitoring of the in vivo distribution of infused mesenchymal stem cells in a mouse model of the graft-versus-host reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Murine models of chronic graft-versus-host disease: insights and unresolved issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Modulation of autoimmunity by TLR9 in the chronic graft-vs-host model of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Homing and engraftment of progenitor cells: a prerequisite for cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Mesenchymal stem cell homing: the devil is in the details

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1796-Z

10.1007/S00277-013-1796-Z

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722500%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference